Systematic Reviews
Copyright ©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 14, 2014; 20(30): 10628-10636
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10628
Selection of treatment modalities for Budd-Chiari Syndrome in China: A preliminary survey of published literature
Xing-Shun Qi, Wei-Rong Ren, Dai-Ming Fan, Guo-Hong Han
Xing-Shun Qi, Wei-Rong Ren, Dai-Ming Fan, Guo-Hong Han, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an 710000, Shaanxi Province, China
Xing-Shun Qi, Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang 110840, Liaoning Province, China
Xing-Shun Qi, Department of Gastroenterology, No. 463 Hospital of Chinese PLA, Shenyang 110000, Liaoning Province, China
Author contributions: Qi XS designed the work; Qi XS and Ren WR collected the data; Qi XS, Ren WR, Fan DM and Han GH analyzed and interpreted the data; Qi XS drafted the manuscript; Fan DM and Han GH made critical revision of the manuscript; Qi XS and Ren WR contributed equally to this work.
Correspondence to: Guo-Hong Han, Professor, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, No. 27 West Changle Road, Xi’an 710032, Shaanxi Province, China. guohhan@126.com
Telephone: +86-29-84771537 Fax: +86-29-82539041
Received: December 19, 2013
Revised: March 29, 2014
Accepted: April 30, 2014
Published online: August 14, 2014
Processing time: 241 Days and 20.3 Hours
Abstract

AIM: To evaluate the frequency of use of various treatment modalities for Budd-Chiari syndrome (BCS) in China by conducting a preliminary survey of relevant literature.

METHODS: All papers regarding the treatment of BCS in Chinese patients were identified by searching PubMed, Chinese Scientific and Technological Journal, and China National Knowledge Infrastructure databases. Data regarding the number of BCS patients treated with different treatment modalities over time were collected. The proportions of BCS patients undergoing various treatment modalities were calculated.

RESULTS: Overall, 300 of 3005 papers initially retrieved were included. These papers included 23352 BCS patients treated with different treatment modalities. The treatment modalities include surgery (n = 8625), interventional treatment (n = 13940), surgery combined with interventional treatment (n = 363), medical therapy (n = 277), other treatments (n = 91), and no treatment (n = 56). After 2005, the number of BCS patients treated with surgery was drastically decreased, but the number of BCS patients who underwent interventional treatment was almost maintained. Shunt surgery was the most common type of surgery (n = 3610). Liver transplantation was rarely employed (n = 2). Balloon angioplasty with or without stenting was the most common type of interventional treatment (n = 13747). Transjugular intrahepatic portosystemic shunt was rarely employed (n = 81).

CONCLUSION: Selection of treatment modalities for BCS might be different between China and Western countries. Further work should be necessary to establish a unanimous therapeutic strategy for BCS in China.

Keywords: Budd-Chiari syndrome; Treatment; Surgery; Percutaneous recanalization; Transjugular intrahepatic portosystemic shunt

Core tip: This preliminary survey of published literature demonstrated that the selection of treatment modalities for Budd-Chiari syndrome (BCS) might be different between China and Western countries. Balloon angioplasty with or without stenting, also known as percutaneous recanalization, was the most common treatment modality for BCS in China.